TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2014933

Group type: EXPERIMENTAL
Intervention: Volmax, 8 mg bid
Number of subjects: 38

Group type: COMPARATOR
Intervention: Proventil Repetabs, 8 mg (as two 4-mg tablets) bid
Number of subjects: 38

Group type: COMPARATOR
Intervention: Volmax and Proventil Repetabs
Number of subjects: 38
Study: 12338165

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Alclofenac
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Flufenamic acid
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31287141

Group type: EXPERIMENTAL
Intervention: Genetically predicted linoleic acid (LA)
Number of subjects: 19954
Study: 29203772

Group type: EXPERIMENTAL
Intervention: Peanut oral challenge
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 25658929

Group type: EXPERIMENTAL
Intervention: Short-form mindfulness-based stress reduction
Number of subjects: 23
Study: 23899913

Group type: EXPERIMENTAL
Intervention: Standard practice investigations plus additional monitoring (SP-AM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard practice investigations (SP)
Number of subjects: 100
Study: 21088591

Group type: EXPERIMENTAL
Intervention: Temporary mid‐forearm tourniquet for 8 min during and after administration of local anaesthetic
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no tourniquet)
Number of subjects: 50
Study: 19762295

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 228

Group type: COMPARATOR
Intervention: Non-nutritive sucking-placebo
Number of subjects: 228

Group type: COMPARATOR
Intervention: Non-nutritive sucking-24% sucrose
Number of subjects: 228

Group type: COMPARATOR
Intervention: Other analgesic procedures
Number of subjects: 228
Study: 17974114

Group type: EXPERIMENTAL
Intervention: VISIT navigation system
Number of subjects: 16

Group type: COMPARATOR
Intervention: Medtronic StealthStation Treon navigation system
Number of subjects: 16
Study: 15347340

Group type: EXPERIMENTAL
Intervention: Bepotastine (10 mg twice a day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg once a day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Fexofenadine (60 mg twice a day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Olopatadine (5 mg twice a day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 11394422

Group type: EXPERIMENTAL
Intervention: Laparoscopic laser surgery
Number of subjects: 56
Study: 9868589

Group type: EXPERIMENTAL
Intervention: Antioxidants from food; specific dosage and duration not available.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antioxidant therapy; specific details not available.
Number of subjects: 0
Study: 7993987

Group type: EXPERIMENTAL
Intervention: Two 10 mg controlled-release nifedipine tablets (Adalat Retard, Bayer), administered 12 hourly
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: One 20 mg controlled-release nifedipine tablet (Adalat Retard, Bayer), administered 12 hourly
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Two 30 mg nifedipine gastro-intestinal therapeutic system (GITS) tablets (Adalat XL, Bayer), administered once daily
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: One 60 mg nifedipine GITS tablet (Adalat XL, Bayer), administered once daily
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: One 20 mg plus one 10 mg nifedipine controlled-release tablet (Adalat Retard, Bayer), administered 12 hourly
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS products (Adalat XL)
Number of subjects: 46
Study: 2839742

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including phone calls from nurses, mailings of appointment reminders, lists of early warning signs, and prompt rescheduling of visit failures
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention for high-risk patients (N = 181)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Control group for high-risk patients (N = 181)
Number of subjects: 1001
Study: 31790904

Group type: EXPERIMENTAL
Intervention: Case-finding strategy (history taking, physical examination, blood tests, electrocardiography, spirometry, and echocardiography)
Number of subjects: 829

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Case-finding strategy
Number of subjects: 829
Study: 31489810

Group type: EXPERIMENTAL
Intervention: Preoperative respiratory muscle endurance training (RMET) for 3 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (C group) with usual chest physical therapy only
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Preoperative respiratory muscle endurance training (RMET)
Number of subjects: 26
Study: 28060065

Group type: EXPERIMENTAL
Intervention: SS-OCT
Number of subjects: 29
Study: 25721152

Group type: EXPERIMENTAL
Intervention: SIT‐12 olfactory screening test
Number of subjects: 100
Study: 23062403

Group type: EXPERIMENTAL
Intervention: 5-month educational and playful intervention
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Usual curriculum
Number of subjects: 1216
Study: 21868252

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) preconditioning for 5 days before surgery in on‐pump patients
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (on‐pump surgery without HBO)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) preconditioning for 5 days before surgery in off‐pump patients
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (off‐pump surgery without HBO)
Number of subjects: 49
Study: 18834731

Group type: EXPERIMENTAL
Intervention: Oral diazepam 10 mg (n = 65)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (n = 65)
Number of subjects: 130
Study: 17176914

Group type: EXPERIMENTAL
Intervention: EVAL membrane
Number of subjects: 11

Group type: COMPARATOR
Intervention: VE-C membrane
Number of subjects: 11

Group type: COMPARATOR
Intervention: PS membrane
Number of subjects: 11
Study: 15065315

Group type: EXPERIMENTAL
Intervention: Guideline adherence (YES-GL)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Normal clinical practice (NO-GL)
Number of subjects: 123
Study: 10812581

Group type: EXPERIMENTAL
Intervention: ciprofibrate 100 mg
Number of subjects: 13
Study: 8849609

Group type: EXPERIMENTAL
Intervention: Echocardiographic automated border detection (ABD)
Number of subjects: 42
Study: 1290434

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg induction dose
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Danazol 200 mg maintenance dose
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Danazol 50 mg and 100 mg maintenance doses
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6365158

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Arnica Montana
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 31006420

Group type: EXPERIMENTAL
Intervention: Brown rice regimen (parboiled brown rice)
Number of subjects: 166
Study: 28947365

Group type: EXPERIMENTAL
Intervention: DEE transarterial chemoembolization (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: TAE (n = 5)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DEE transarterial chemoembolization (n = 4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both DEE and TAE
Number of subjects: 12
Study: 26952125

Group type: EXPERIMENTAL
Intervention: Continuous-flush
Number of subjects: 50
Study: 25141094

Group type: EXPERIMENTAL
Intervention: Inclusion of female athletes' weights in athletic event programs
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Heavier athletes vs. less heavy athletes
Number of subjects: 152
Study: 21922202

Group type: EXPERIMENTAL
Intervention: 4 mg betamethasone i.v. prior to vinorelbine infusion
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo i.v. prior to vinorelbine infusion
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 20 ml saline infusion post vinorelbine infusion
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: 250 ml saline infusion post vinorelbine infusion
Number of subjects: 79
Study: 20076843

Group type: EXPERIMENTAL
Intervention: Low-intensity warfarin therapy (INR target 1.8, range 1.5-2.0)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Standard-intensity warfarin therapy (INR target 2.5, range 2.0-3.0)
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Low-intensity warfarin therapy
Number of subjects: 267

Group type: COMPARATOR
Intervention: Standard-intensity warfarin therapy
Number of subjects: 267
Study: 17407215

Group type: EXPERIMENTAL
Intervention: PYD/exercise
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo/exercise
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: PYD/diet recall
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo/diet recall
Number of subjects: 165
Study: 15827573

Group type: EXPERIMENTAL
Intervention: OROS MPH 18 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: OROS MPH 36 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: OROS MPH 54 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 12485320

Group type: EXPERIMENTAL
Intervention: Exposure to fungi (molds and yeasts) in children attending a water-damaged school
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unexposed children of the same age
Number of subjects: 0
Study: 9835257

Group type: EXPERIMENTAL
Intervention: Aspirin (n = 30)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ticlopidine (n = 29)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Combined aspirin and ticlopidine (nonrandomized group III, n = 31)
Number of subjects: 59
Study: 7861711

Group type: EXPERIMENTAL
Intervention: IDDM adolescents with microalbuminuria (MA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: IDDM adolescents without microalbuminuria (non-MA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Combined IDDM group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control siblings of MA subgroup
Number of subjects: 50
Study: 2570104

Group type: EXPERIMENTAL
Intervention: Penicillin for 1 day
Number of subjects: 423

Group type: COMPARATOR
Intervention: Penicillin for 5 days
Number of subjects: 423
Study: 894653

Group type: EXPERIMENTAL
Intervention: Digital stripping of the membranes from the lower uterine segment
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Membrane stripping
Number of subjects: 91
Study: 28128982

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Armodafinil (a wakefulness promoting agent)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 96
Study: 28687496

Group type: EXPERIMENTAL
Intervention: Romosozumab 210mg QM
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Romosozumab 70mg QM
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Romosozumab 140mg QM
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Romosozumab (all doses)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 26010952

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) - 40 sessions, 5 days/week, 90 minutes, 100% oxygen at 2ATA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control period (no treatment)
Number of subjects: 60
Study: 23124582

Group type: EXPERIMENTAL
Intervention: Test messages
Number of subjects: 2020

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 2020
Study: 21787045

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Individual therapy (IT)
Number of subjects: 176
Study: 19420918

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 16958717

Group type: EXPERIMENTAL
Intervention: Prenatal breastfeeding workshop
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no workshop)
Number of subjects: 110
Study: 15238993

Group type: EXPERIMENTAL
Intervention: (-)-linalool
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 14
Study: 10590454

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 50
Study: 9132194

Group type: EXPERIMENTAL
Intervention: Intranasal diamorphine (0.1 mg/kg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intramuscular morphine (0.2 mg/kg)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intranasal diamorphine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 58
Study: 8140393

Group type: EXPERIMENTAL
Intervention: 5‐Fluoro‐Uracil + leucovorin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5‐Fluoro‐Uracil + interferon alpha‐2‐a
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5‐Fluoro‐Uracil + leucovorin or 5‐Fluoro‐Uracil + interferon alpha‐2‐a
Number of subjects: 16
Study: 3539046

Group type: EXPERIMENTAL
Intervention: 12 mg of ivermectin in a single dose
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1300 mg of diethylcarbamazine over eight days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Matching placebo capsules
Number of subjects: 59
Study: 29846976

Group type: EXPERIMENTAL
Intervention: Ixekizumab (every 2 weeks or 4 weeks)
Number of subjects: 3126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3126
Study: 30250339

Group type: EXPERIMENTAL
Intervention: Single-dose del Nido cardioplegia (DNC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Multidose conventional blood cardioplegia (CBC)
Number of subjects: 30
Study: 26539964

Group type: EXPERIMENTAL
Intervention: Galectin-3
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Osteopontin
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Gremlin-1
Number of subjects: 401
Study: 25272531

Group type: EXPERIMENTAL
Intervention: Cyclosporine (3mg/kg)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Tacrolimus (0.1mg/kg)
Number of subjects: 182
Study: 22458722

Group type: EXPERIMENTAL
Intervention: Nurse researchers engaging in clinical research communication
Number of subjects: 0
Study: 20624281

Group type: EXPERIMENTAL
Intervention: Decompressive laparotomy with temporary abdominal closure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Percutaneous puncture with placement of abdominal catheter
Number of subjects: 100
Study: 17983374

Group type: EXPERIMENTAL
Intervention: HDM avoidance intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15863546

Group type: EXPERIMENTAL
Intervention: E+P (0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate)
Number of subjects: 16608
Study: 11873001

Group type: EXPERIMENTAL
Intervention: Phenotypic resistance testing (PRT)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 272
Study: 9462523

Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate (5-MTHF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control subjects (matched, N=10)
Number of subjects: 10
Study: 7622762

Group type: EXPERIMENTAL
Intervention: Albuterol 200 micrograms four times daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo 2 puffs four times daily
Number of subjects: 11
Study: 2709673

Group type: EXPERIMENTAL
Intervention: 45 kcal/kg desirable body weight/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 35 kcal/kg desirable body weight/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 25 kcal/kg desirable body weight/day
Number of subjects: 6
Study: 334607

Group type: EXPERIMENTAL
Intervention: Enteric-coated phenylbutazone (Butacote)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard phenylbutazone (Butazolidine)
Number of subjects: 50
Study: 30741360

Group type: EXPERIMENTAL
Intervention: Zio XT Monitor (ZM)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: NUUBO Vest (NV)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Carnation Ambulatory Monitor (CAM)
Number of subjects: 21

Group type: COMPARATOR
Intervention: RT (Novacor 'R' Test 4)
Number of subjects: 21
Study: 30930074

Group type: EXPERIMENTAL
Intervention: SP-ESD
Number of subjects: 91

Group type: COMPARATOR
Intervention: S-ESD
Number of subjects: 91
Study: 27925235

Group type: EXPERIMENTAL
Intervention: MiECC
Number of subjects: 150

Group type: COMPARATOR
Intervention: cCPB
Number of subjects: 150
Study: 25516008

Group type: EXPERIMENTAL
Intervention: Instruction to approach fictitious social groups (Niffites and Luupites)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instruction to avoid fictitious social groups (Niffites and Luupites)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instruction to approach well-known social groups (Blacks and Whites)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Instruction to avoid well-known social groups (Blacks and Whites)
Number of subjects: 0
Study: 24087909

Group type: EXPERIMENTAL
Intervention: Computerized working memory training (Cogmed QM)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Integrated rehabilitation (Control Group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups (IG and CG)
Number of subjects: 47
Study: 21366432

Group type: EXPERIMENTAL
Intervention: Rehabilitation similar to currently used protocols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active cooling and nutritional intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 19478715

Group type: EXPERIMENTAL
Intervention: Intratympanic injection of prednisolone
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Intratympanic injection of dexamethasone
Number of subjects: 79

Group type: COMPARATOR
Intervention: Oral carbamazepine
Number of subjects: 79
Study: 16750449

Group type: EXPERIMENTAL
Intervention: Valdecoxib 20 mg BID
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg BID
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 15221569

Group type: EXPERIMENTAL
Intervention: Surgical intervention including discectomy and fusion on one or two levels with cage, plate, and screws; corpectomy in severe cases; combined approach with dorsal decompression and ventral fusion in one case.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 16
Study: 11693321

Group type: EXPERIMENTAL
Intervention: Eradication therapy + omeprazole 40 mg once daily for 12 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: H. pylori persistent group
Number of subjects: 71

Group type: COMPARATOR
Intervention: H. pylori negative group
Number of subjects: 71
Study: 9926054

Group type: EXPERIMENTAL
Intervention: Intensive community treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard community treatment
Number of subjects: 0
Study: 7941938

Group type: EXPERIMENTAL
Intervention: suxamethonium
Number of subjects: 54

Group type: COMPARATOR
Intervention: vecuronium
Number of subjects: 54
Study: 2836059

Group type: EXPERIMENTAL
Intervention: i.v. melphalan with concomitant oral misonidazole
Number of subjects: 100

Group type: COMPARATOR
Intervention: i.v. melphalan
Number of subjects: 100
Study: 31886700

Group type: EXPERIMENTAL
Intervention: Text message interventions
Number of subjects: 296
Study: 29710726

Group type: EXPERIMENTAL
Intervention: ADD-continuation group (N=30)
Number of subjects: 65

Group type: COMPARATOR
Intervention: ADD-discontinuation group (N=35)
Number of subjects: 65
Study: 27183075

Group type: EXPERIMENTAL
Intervention: Microthreaded coronal aspect implants (Hexplant)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Rough-surface implants (Brånemark)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Machined coronal aspect implants (Restore)
Number of subjects: 54
Study: 26092063

Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg per day
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Teriparatide 40 μg per day
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 or 40 μg per day combined)
Number of subjects: 1637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1637
Study: 23780370

Group type: EXPERIMENTAL
Intervention: Mild cold exposure at 19 °C
Number of subjects: 31
Study: 20936540

Group type: EXPERIMENTAL
Intervention: Remune and ALVAC
Number of subjects: 49
Study: 19050299

Group type: EXPERIMENTAL
Intervention: AMA1-specific Abs induced by vaccination (U.S.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AMA1-specific Abs induced by natural infection (Mali)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mali-non-AMA1 IgG
Number of subjects: 0

Group type: COMPARATOR
Intervention: U.S.-non-AMA1 IgGs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AMA1-based vaccines
Number of subjects: 0
Study: 16880017

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment of MTBI
Number of subjects: 191

Group type: COMPARATOR
Intervention: Nontreatment (control)
Number of subjects: 191
Study: 14652301

Group type: EXPERIMENTAL
Intervention: Baseline waist circumference
Number of subjects: 2739

Group type: EXPERIMENTAL
Intervention: Baseline body mass index (BMI)
Number of subjects: 2739

Group type: EXPERIMENTAL
Intervention: Weight and waist circumference cycling
Number of subjects: 2739
Study: 10946987

Group type: EXPERIMENTAL
Intervention: Intraoperative PAR Corneal Topography System (IOPAR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Slit lamp PAR CTS
Number of subjects: 26

Group type: COMPARATOR
Intervention: EyeSys Corneal Analysis System (EyeSys CAS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Manual keratometer (Mnl‐Km)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Autokeratometer (Auto‐Km)
Number of subjects: 26
Study: 8869671

Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg kg‐1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg kg‐1
Number of subjects: 24
Study: 1892362

Group type: EXPERIMENTAL
Intervention: Combination of dipyridamole, 75 mg, and acetylsalicylic acid, 330 mg, three times a day
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Combination of dipyridamole and acetylsalicylic acid
Number of subjects: 2500